Oxigene Logo spacer
Learn More Graphic
Investors Graphic

nav_investor_overview Management Board of Directors nav_corporate_alliance nav_corporate_contact
  Management

OXiGENE is led by a talented team of business, medical, and drug development / discovery professionals with extensive biopharmaceutical industry experience.

Peter J. Langecker, M.D., Ph.D
Chief Executive Officer

Dai Chaplin, Ph.D.
Advisor

James B. Murphy
Vice President and Chief Financial Officer

Back to Top
 
Pipeline
spacer Stock Quote Graphic spacer
More Button
spacer
Related Info
spacer spacer

Product Pipeline

OXiGENE Clinical Trials

Investor Center

spacer
More Button